Leaflet RIGEVIDON 21+7 0.030mg / 0.150mg sugar-coated tablets
Indicated for: contraception
Route of administration: oral
Substance: ethinylestradiol + levonorgestrel (estrogen + progestogen)
ATC: G03AA07 (Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Ethinylestradiol and levonorgestrel are a combination of hormones commonly used in oral contraceptives. This medication prevents pregnancy by inhibiting ovulation, altering cervical mucus, and changing the uterine lining so that sperm cannot fertilize the egg.
It is taken daily, usually at the same time, according to the instructions on the blister pack. It is important not to miss any dose to maintain contraceptive effectiveness.
Side effects may include nausea, headaches, changes in the menstrual cycle, breast tenderness, or, rarely, allergic reactions and an increased risk of thrombosis. Smoking and age over 35 can increase the risk of serious side effects.
The combination of ethinylestradiol and levonorgestrel is effective for preventing pregnancy, but its use should be supervised by a doctor, especially if there are risk factors or other medical conditions.
General data about RIGEVIDON 21+7 0.030mg / 0.150mg
- Substance: ethinylestradiol + levonorgestrel
- Date of latest medicines list: 01-06-2026
- Product code: W01969001
- Concentration: 0.030mg / 0.150mg
- Pharmaceutical form: sugar-coated tablets
- Quantity: 21
- Product type: Generic medicine
- Price: 10.51 RON
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.